RxDoctor Payments Data

Kerry Thibodeaux, MD

Surgery · Opelousas, LANPI 1093774192

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $57,029 of the $83,767 with a category attached, or 68.1%. 14 manufacturers reported payments, led by Organogenesis Inc. at 57.0% of the total. Reporting peaked in 2019 at $52,061 and has fallen 99.1% since, to $455 in 2025. Among surgery clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$83,767in general payments, 2019–2025

Across 242 payments — averaging $346.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$48K
  • KCI USA, Inc.$34K
  • Aroa Biosurgery Incorporated$1K
  • Kerecis Limited$280
  • ETS Wound Care LLC$275
  • Hartmann USA, Inc.$122
  • plus $557 from 8 others
$16,719in research payments, 2019–2025

Across 9 payments — averaging $1857.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Organogenesis Inc.$13K
  • Reapplix Inc.$4K

What the payments were for

  • Consulting fees$12,20015%
  • Speaking & faculty fees$57,02968%
  • Travel & lodging$8,97011%
  • Food & beverage$5,3736%
  • Education$1950%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,767 in reported general payments places this provider in the 95th percentile of 381 surgery providers in Louisiana.

See all surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$58,885
Medicare patients
174
Services billed
816

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$484
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$419
Doxycycline Hyclate12$115
Methylprednisolone13$78
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$54

Paid to pharmacies, not to this prescriber.

Other surgery in Opelousas

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →